Cash From Investing Activities - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GlaxoSmithKline PLC
Cash from Investing Activities Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Cash from Investing Activities
ÂŁ398m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-7%
A
AstraZeneca PLC
NASDAQ:AZN
Cash from Investing Activities
-$7.6B
CAGR 3-Years
-295%
CAGR 5-Years
-379%
CAGR 10-Years
-1%
Indivior PLC
LSE:INDV
Cash from Investing Activities
$32m
CAGR 3-Years
N/A
CAGR 5-Years
40%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Cash from Investing Activities
-$320m
CAGR 3-Years
-4%
CAGR 5-Years
-27%
CAGR 10-Years
-10%
Allergy Therapeutics PLC
LSE:AGY
Cash from Investing Activities
-ÂŁ3.5m
CAGR 3-Years
-16%
CAGR 5-Years
-9%
CAGR 10-Years
-10%
Dechra Pharmaceuticals PLC
LSE:DPH
Cash from Investing Activities
-ÂŁ426.2m
CAGR 3-Years
-74%
CAGR 5-Years
-12%
CAGR 10-Years
-36%

See Also

What is GlaxoSmithKline PLC's Cash from Investing Activities?
Cash from Investing Activities
398m GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Cash from Investing Activities amounts to 398m GBP.

What is GlaxoSmithKline PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-7%

Back to Top